Persistent Identifier
|
doi:10.7910/DVN/SKUUOP |
Publication Date
|
2021-12-02 |
Title
| REVAMP Clinical Trial Dataset |
Alternative Title
| Resistance Testing for Management of HIV Virologic Failure in Sub-Saharan Africa |
Other Identifier
| clinicaltrials.gov: NCT02787499 |
Author
| Siedner. MarkMGHORCID0000-0003-3506-842X |
Point of Contact
|
Use email button above to contact.
Siedner, Mark (MGH) |
Description
| Data are derived from the Resistance Testing for Management of HIV Virologic Failure in Sub-Saharan Africa (REVAMP) clinical trial. The de-identified dataset includes include randomization allocation, baseline participant characteristics and primary and secondary outcomes. (2021-11-17) |
Subject
| Medicine, Health and Life Sciences |
Keyword
| HIV, resistance, virologic failure, africa |
Related Publication
| Siedner MJ, Moosa MS, McCluskey S, Gilbert RF, Pillay S, Aturinda I, Ard K, Muyindike W, Musinguzi N, Masette G, Pillay M, Moodley P, Brijkumar J, Rautenberg T, George G, Gandhi RT, Johnson BA, Sunpath H, Bwana MB, Marconi VC. Resistance Testing for Management of HIV Virologic Failure in Sub-Saharan Africa : An Unblinded Randomized Controlled Trial. Ann Intern Med. 2021 Oct 26. PMID: 34698502. doi 10.7326/M21-2229
Reynolds Z, McCluskey SM, Moosa MYS, Gilbert RF, Pillay S, Aturinda I, Ard KL, Muyindike W, Musinguzi N, Masette G, Moodley P, Brijkumar J, Rautenberg T, George G, Johnson BA, Gandhi RT, Sunpath H, Marconi VC, Bwana MB, Siedner MJ. Who's slipping through the cracks? A comprehensive individual, clinical and health system characterization of people with virological failure on first-line HIV treatment in Uganda and South Africa. HIV Med. 2021 PMID: 34755438 doi 10.1111/hiv.13203
Rautenberg TA, George G, Bwana MB, Moosa MS, Pillay S, McCluskey SM, Aturinda I, Ard K, Muyindike W, Moodley P, Brijkumar J, Johnson BA, Gandhi RT, Sunpath H, Marconi VC, Siedner MJ. Comparative analyses of published cost effectiveness models highlight critical considerations which are useful to inform development of new models. J Med Econ. 2020 Mar;23(3):221-227. PMID: 31835974 doi 10.1080/13696998.2019
Siedner MJ, Bwana MB, Moosa MS, Paul M, Pillay S, McCluskey S, Aturinda I, Ard K, Muyindike W, Moodley P, Brijkumar J, Rautenberg T, George G, Johnson B, Gandhi RT, Sunpath H, Marconi VC. The REVAMP trial to evaluate HIV resistance testing in sub-Saharan Africa: a case study in clinical trial design in resource limited settings to optimize effectiveness and cost effectiveness estimates. HIV Clin Trials. 2017 07; 18(4):149-155. PMID: 28720039. doi 10.1080/15284336.2017.1349028 |
Funding Information
| NIH/NIAID: R01AI124718 |
Depositor
| Reynolds, Zahra |
Deposit Date
| 2021-11-17 |
Date of Collection
| Start Date: 2016-12-01; End Date: 2020-05-01 |
Data Type
| survey data, clinical trial data |